MRI may have a sweet new contrast partner

German scientists have developed a way to swap out contrast agents for a simple sugar solution to enhance brain cancer visualization on MRI.

According to materials posted by the German Cancer Research Institute, the method isn’t new but has never been used in humans—till now.

The researchers say they applied magnetization transfer to send signals from glucose protons to bodily water for measuring via MRI. Using glucose in amounts equal to about five sugar cubes, they were able to observe changes of glucose signals in healthy brain regions as well as pathogenic changes in human brain cancer, the institute reports.

“If we can confirm that substantial signal levels originate from glucose in the cell interior, this would be important additional information for tumor imaging and functional MRI,” says radiologist Heinz-Peter Schlemmer, MD. “This could enhance therapy planning and monitoring.”

Read the rest:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.